| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Clinical Outcomes in Patients With Refractory Anemia With Excess Blasts (RAEB) Who Receive Hypomethylating Agents (HMAs)
|
Zeidan, Amer M.
|
|
|
24 |
3 |
p. 177-186
|
artikel
|
| 2 |
Concordance of Next-Generation Sequencing and Multiparametric Flow Cytometry Methods for Detecting Measurable Residual Disease in Adult Acute Lymphoblastic Leukemia: Optimizing Prediction of Clinical Outcomes From a Single-Center Study
|
Ashouri, Karam
|
|
|
24 |
3 |
p. e59-e66.e2
|
artikel
|
| 3 |
Corrigendum to “AML-068 - Survival Differences in Patients With Acute Myeloid Leukemia (AML) Treated With Oral Azacitidine (Oral-AZA) as Maintenance and Those Eligible but Not Treated in a US Electronic Health Record (EHR) Database” [Clinical Lymphoma, Myeloma & Leukemia, 23S1 (2023) S1-S593]
|
Mims, Alice
|
|
|
24 |
3 |
p. 203-204
|
artikel
|
| 4 |
Editorial Board
|
|
|
|
24 |
3 |
p. A4-A5
|
artikel
|
| 5 |
Impact of Folinic Acid Dosing on Efficacy and Toxicity of High-Dose Methotrexate in Central Nervous System Lymphoma
|
Haran, Arnon
|
|
|
24 |
3 |
p. 187-193.e1
|
artikel
|
| 6 |
Improvements in Patient-Reported Outcomes in Relapsed or Refractory Large B-Cell Lymphoma Patients Treated With Epcoritamab
|
Phillips, Tycel
|
|
|
24 |
3 |
p. e78-e87.e2
|
artikel
|
| 7 |
Long-Term Follow-Up in Patients With Chronic Myeloid Leukemia Treated With Ponatinib in a Real-World Cohort: Safety and Efficacy Analysis
|
Mela Osorio, María José
|
|
|
24 |
3 |
p. 158-164
|
artikel
|
| 8 |
Multiparametric Flow Cytometry in the Evaluation of Plasma Cell Proliferative Disorders: Current Paradigms for Clinical Practice
|
Gupta, Ritu
|
|
|
24 |
3 |
p. e88-e95
|
artikel
|
| 9 |
Multiple Myeloma: Validation of the Values and Preferences Elicitation Questionnaire- Cure and Survival Preference Scale (VPEQ-CSPS)
|
Savchenko, Anastasiia
|
|
|
24 |
3 |
p. e96-e103
|
artikel
|
| 10 |
Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment
|
Oriol, Albert
|
|
|
24 |
3 |
p. 165-176.e4
|
artikel
|
| 11 |
Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma
|
Goldman-Mazur, Sarah
|
|
|
24 |
3 |
p. e104-e111.e1
|
artikel
|
| 12 |
Real-World Effectiveness of Dasatinib Versus Imatinib in Newly Diagnosed Patients With Chronic Myeloid Leukemia
|
Klink, Andrew J.
|
|
|
24 |
3 |
p. 149-157
|
artikel
|
| 13 |
SOHO State of the Art Update and Next Questions: Novel Therapies for Polycythemia Vera
|
Masarova, Lucia
|
|
|
24 |
3 |
p. 141-148
|
artikel
|
| 14 |
SOHO State of the Art Updates and Next Questions | Approach to Older Adults With Phildadelphia-Chromosome Negative Acute Lymphoblastic Leukemia
|
Shimony, Shai
|
|
|
24 |
3 |
p. 133-140
|
artikel
|
| 15 |
Table of Contents
|
|
|
|
24 |
3 |
p. A6-A8
|
artikel
|
| 16 |
Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study
|
Martin, Thomas G.
|
|
|
24 |
3 |
p. 194-202
|
artikel
|
| 17 |
The Impact of Time From Diagnosis to Initiation of Chemotherapy on Survival of Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma in the Veterans Health Administration
|
Roman Souza, Gabriel
|
|
|
24 |
3 |
p. e67-e77
|
artikel
|
| 18 |
The Prognostic Significance of Vitamin D Deficiency in Korean Patients With Multiple Myeloma
|
Kim, Sejin
|
|
|
24 |
3 |
p. e112-e118
|
artikel
|
Tijdschrift beschrijving